Loading publications…
The last 5 uploaded publications
Percutaneous Recanalization of Chronically Occluded Coronary Arteries
Gregg W. Stone, David E. Kandzari, Roxana Mehran, Antonio Colombo, Robert S. Schwartz, Steven R. Bailey, Issam Moussa, Paul S. Teirstein, George Dangas, Donald S. Baim, Matthew R. Selmon, Bradley H. Strauss, Hideo Tamai, Takahiko Suzuki, Kazuaki Mitsudo, Osamu Katoh, David A. Cox, Angela Hoye, Gary S. Mintz, Eberhard Grube, Louis Cannon, Nicolaus Reifart, Mark Reisman, Alexandre Abizaid, Jeffrey W. Moses, Martin B. Leon, Patrick W. Serruys (2005). Percutaneous Recanalization of Chronically Occluded Coronary Arteries. Circulation, 112(15), pp. 2364-2372, DOI: 10.1161/circulationaha.104.481283.
Article146 days agoAspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Davide Capodanno, Roxana Mehran, Marco Valgimigli, Usman Baber, Stephan Windecker, Pascal Vranckx, George Dangas, Fabiana Rollini, Takeshi Kimura, Jean‐Philippe Collet, C. Michael Gibson, Philippe Gabríel Steg, Renato D. Lópes, Hyeon‐Cheol Gwon, Robert F. Storey, Francesco Franchi, Deepak L. Bhatt, Patrick W. Serruys, Dominick J. Angiolillo (2018). Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention. Nature Reviews Cardiology, 15(8), pp. 480-496, DOI: 10.1038/s41569-018-0049-1.
Article146 days agoP2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Marco Valgimigli, Felice Gragnano, Mattia Branca, Anna Franzone, Usman Baber, Yangsoo Jang, Takeshi Kimura, Joo‐Yong Hahn, Qiang Zhao, Stephan Windecker, C. Michael Gibson, Byeong‐Keuk Kim, Hirotoshi Watanabe, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir R. Mehta, Sung‐Jin Hong, Kenji Andò, Hyeon‐Cheol Gwon, Patrick W. Serruys, George Dangas, Eugène McFadden, Dominick J. Angiolillo, Dik Heg, Peter Jüni, Roxana Mehran (2021). P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials. BMJ, pp. n1332-n1332, DOI: 10.1136/bmj.n1332.
Article146 days agoP2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
Felice Gragnano, Roxana Mehran, Mattia Branca, Anna Franzone, Usman Baber, Yangsoo Jang, Takeshi Kimura, Joo‐Yong Hahn, Qiang Zhao, Stephan Windecker, C. Michael Gibson, Byeong‐Keuk Kim, Hirotoshi Watanabe, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir R. Mehta, Sung‐Jin Hong, Giuseppe Andò, Hyeon‐Cheol Gwon, Paolo Calabrò, Patrick W. Serruys, George Dangas, Eugène McFadden, Dominick J. Angiolillo, Dik Heg, Marco Valgimigli (2023). P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions. Journal of the American College of Cardiology, 81(6), pp. 537-552, DOI: 10.1016/j.jacc.2022.11.041.
Article146 days agoTicagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Marco Valgimigli, Felice Gragnano, Mattia Branca, Anna Franzone, Bruno R. da Costa, Usman Baber, Takeshi Kimura, Yangsoo Jang, Joo‐Yong Hahn, Qiang Zhao, Stephan Windecker, C. Michael Gibson, Hirotoshi Watanabe, Byeong‐Keuk Kim, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir R. Mehta, Giuseppe Andò, Sung‐Jin Hong, Hyeon‐Cheol Gwon, Patrick W. Serruys, George Dangas, Eugène McFadden, Dominick J. Angiolillo, Dik Heg, Paolo Calabrò, Peter Jüni, Roxana Mehran (2024). Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. JAMA Cardiology, 9(5), pp. 437-437, DOI: 10.1001/jamacardio.2024.0133.
Article146 days ago